The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Clindaseptin 300 mg capsules for dogs

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/163/004

Main Information

Trade NameClindaseptin 300 mg capsules for dogs
Active SubstancesClindamycin hydrochloride
Dosage FormCapsule
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/163/004

Group Information

ATC CodeQJ01FF01 clindamycin
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued28/06/2013
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back